Table 1.

Dexamethasone Suppressed Human IL-5 Promoter/Enhancer Activity Induced by Either TCR or IL-2R Stimulation

Clone*StimulationDexLuciferase Activityρ (per μg protein)β-Galactosidase Activityρ (per μg protein)
YA5 None − 10.9 ± 1.0 0.67 ± 0.07 
 Anti-CD3 − 192.4 ± 12.2 0.59 ± 0.08 
  21.0 ± 2.0 0.62 ± 0.07 
 IL-2 − 118.2 ± 10.0 0.66 ± 0.08 
  17.2 ± 1.2 0.69 ± 0.06 
HK5 None − 4.2 ± 1.0 0.92 ± 0.08 
 Anti-CD3 − 479.2 ± 30.9 0.87 ± 0.10 
  12.3 ± 1.0 0.97 ± 0.13 
HK2 None − 8.2 ± 1.0 0.72 ± 0.08 
 IL-2 − 269.2 ± 20.1 0.67 ± 0.11 
  9.2 ± 2.9 0.77 ± 0.10 
Clone*StimulationDexLuciferase Activityρ (per μg protein)β-Galactosidase Activityρ (per μg protein)
YA5 None − 10.9 ± 1.0 0.67 ± 0.07 
 Anti-CD3 − 192.4 ± 12.2 0.59 ± 0.08 
  21.0 ± 2.0 0.62 ± 0.07 
 IL-2 − 118.2 ± 10.0 0.66 ± 0.08 
  17.2 ± 1.2 0.69 ± 0.06 
HK5 None − 4.2 ± 1.0 0.92 ± 0.08 
 Anti-CD3 − 479.2 ± 30.9 0.87 ± 0.10 
  12.3 ± 1.0 0.97 ± 0.13 
HK2 None − 8.2 ± 1.0 0.72 ± 0.08 
 IL-2 − 269.2 ± 20.1 0.67 ± 0.11 
  9.2 ± 2.9 0.77 ± 0.10 
*

IL-5–producing T-cell clones (2.5 × 107 cells in 500 mL RPMI1640 medium supplemented with 10% FBS and 10 U/mL rIL-2) were transiently transfected with pIL-5Luc (50 μg) + pCMV-β-gal (10 μg) by electroporation (270 V, 960 μF) using a 0.4-cm cuvette. Transfected cells were suspended in a fresh medium and cultured in triplicate in 24-well culture plates.

Cells were either stimulated with rIL-2 (100 U/mL) or immobilized anti-CD3 MoAb or kept unstimulated for 24 hours.

Dexamethasone (1 μmol/L) was included from the start of some cultures, as indicated..

ρ After 24 hours, cell lysates were prepared and tested for luciferase activity using Luciferase Assay System and β-galactosidase activity using CPRG as a substrate. Protein concentrations were determined with bicinchoninic acid protein assay reagent. Data are presented as the mean of triplicate cultures ± SEM.

or Create an Account

Close Modal
Close Modal